Found: 505
Select item for more details and to access through your institution.
Where are we now in biologic drugs for myositis?
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 2938, doi. 10.1093/rheumatology/keae096
- By:
- Publication type:
- Article
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis.
- Published in:
- Rheumatology, 2024, v. 63, n. 11, p. 3065, doi. 10.1093/rheumatology/kead620
- By:
- Publication type:
- Article
Childhood Arthritis and Rheumatology Research Alliance Biologic Disease‐Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
- Published in:
- Arthritis Care & Research, 2024, v. 76, n. 11, p. 1532, doi. 10.1002/acr.25393
- By:
- Publication type:
- Article
JAK-STAT inhibitors in Immune mediated diseases: An overview.
- Published in:
- Indian Journal of Dermatology, Venereology & Leprology, 2023, v. 89, n. 5, p. 691, doi. 10.25259/IJDVL_1152_2022
- By:
- Publication type:
- Article
Psoriasiform reactions during treatment with abatacept.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Rationale and Design of the Orencia Atherosclerosis and Rheumatoid Arthritis Study (ORACLE Arthritis Study): Implications of Biologics against Rheumatoid Arthritis and the Vascular Complications, Subclinical Atherosclerosis.
- Published in:
- Methods & Protocols, 2021, v. 4, n. 4, p. 83, doi. 10.3390/mps4040083
- By:
- Publication type:
- Article
Systemic lupus erythematosus and lupus nephritis.
- Published in:
- Nature Reviews Drug Discovery, 2014, v. 13, n. 3, p. 173, doi. 10.1038/nrd4227
- By:
- Publication type:
- Article
Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Costo per responder di upadacitinib e abatacept nel trattamento dell'artrite reumatoide da moderata a grave in Italia.
- Published in:
- Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 69, doi. 10.33393/grhta.2021.2267
- By:
- Publication type:
- Article
Influence of the FCGR2A rs1801274 and FCGR3A rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 6, p. 573, doi. 10.3390/jpm11060573
- By:
- Publication type:
- Article
Impact of Single-Nucleotide Polymorphisms of CTLA-4 , CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 220, doi. 10.3390/jpm10040220
- By:
- Publication type:
- Article
The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1000865
- By:
- Publication type:
- Article
Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1046406
- By:
- Publication type:
- Article
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.980832
- By:
- Publication type:
- Article
Yunpi Qufeng Chushi Formula for Pre-Rheumatoid Arthritis: Study Protocol for a Multiple-Center, Double-Blind, Placebo-Controlled Randomized Controlled Trial.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.793394
- By:
- Publication type:
- Article
Alopecia Areata: Current Treatments and New Directions.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 6, p. 895, doi. 10.1007/s40257-023-00808-1
- By:
- Publication type:
- Article
Tofacitinib treatment of rheumatoid arthritis increases senescent T cell frequency in patients and limits T cell function in vitro.
- Published in:
- European Journal of Immunology, 2023, v. 53, n. 8, p. 1, doi. 10.1002/eji.202250353
- By:
- Publication type:
- Article
Evaluation Of The Effectiveness Of Angiotensin-Converting Enzyme Inhibitors, Misoprostol, Omeprazole And Their Combinations On The State Of The Gastric Mucous Barrier In Indomethacin Gastropathy In Animals With Experimental Rheumatoid Arthritis.
- Published in:
- Journal of Pharmaceutical Negative Results, 2022, v. 13, p. 673, doi. 10.47750/pnr.2022.13.S08.85
- By:
- Publication type:
- Article
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 6, p. 1661, doi. 10.3390/pharmaceutics15061661
- By:
- Publication type:
- Article
Biologic Disease-Modifying Antirheumatic Drugs for Preventing Radiographic Progression in Psoriatic Arthritis: A Systematic Review and Network Meta-Analysis.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 10, p. N.PAG, doi. 10.3390/pharmaceutics14102140
- By:
- Publication type:
- Article
Ischemic Optic Neuropathy: A Review of Current and Potential Future Pharmacotherapies.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 10, p. 1281, doi. 10.3390/ph17101281
- By:
- Publication type:
- Article
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 2, p. 248, doi. 10.3390/ph17020248
- By:
- Publication type:
- Article
Pharmacovigilance of Herb-Drug Interactions: A Pharmacokinetic Study on the Combined Administration of Tripterygium Glycosides Tablets and Leflunomide Tablets in Rats by LC-MS/MS.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 8, p. 991, doi. 10.3390/ph15080991
- By:
- Publication type:
- Article
Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Biologics in systemic lupus erythematosus: current options and future perspectives.
- Published in:
- British Journal of Hospital Medicine (17508460), 2014, v. 75, n. 8, p. 440, doi. 10.12968/hmed.2014.75.8.440
- By:
- Publication type:
- Article
Head-to-head trial shows abatacept is as effective as adalimumab in patients with active rheumatoid arthritis.
- Published in:
- British Journal of Hospital Medicine (17508460), 2013, v. 74, n. 8, p. 431, doi. 10.12968/hmed.2013.74.8.431a
- By:
- Publication type:
- Article
Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5368, doi. 10.3390/ijms24065368
- By:
- Publication type:
- Article
Tofacitinib and Baricitinib Are Taken up by Different Uptake Mechanisms Determining the Efficacy of Both Drugs in RA.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6632, doi. 10.3390/ijms21186632
- By:
- Publication type:
- Article
MicroRNA-766-3p Contributes to Anti-Inflammatory Responses through the Indirect Inhibition of NF-κB Signaling.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 4, p. 809, doi. 10.3390/ijms20040809
- By:
- Publication type:
- Article
Efficacy and safety of novel biologics in the treatment of lupus nephritis based on registered clinical trials: a systematic review and network meta-analysis.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3011, doi. 10.1007/s10238-023-01132-y
- By:
- Publication type:
- Article
IL-6-induced response of human osteoblasts from patients with rheumatoid arthritis after inhibition of the signaling pathway.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 7, p. 3479, doi. 10.1007/s10238-023-01103-3
- By:
- Publication type:
- Article
Background Glucocorticoid Therapy Has No Impact on Efficacy and Safety of Abatacept or Adalimumab in Patients with Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 2017, doi. 10.3390/jcm9062017
- By:
- Publication type:
- Article
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric Network.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1528, doi. 10.3390/jcm9051528
- By:
- Publication type:
- Article
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 277, doi. 10.3390/jcm9010277
- By:
- Publication type:
- Article
Anticarcinogenic activity of Cl-Amidine on non-small cell lung cancer.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2024, v. 41, n. 1, p. 80, doi. 10.52142/omujecm.41.1.13
- By:
- Publication type:
- Article
Mycosis fungoides‐like eruptions associated with abatacept.
- Published in:
- Australasian Journal of Dermatology, 2024, v. 65, n. 3, p. e77, doi. 10.1111/ajd.14249
- By:
- Publication type:
- Article
A case of abatacept associated neutrophilic dermatosis and a review of the literature.
- Published in:
- Australasian Journal of Dermatology, 2014, v. 55, n. 3, p. 214, doi. 10.1111/ajd.12185
- By:
- Publication type:
- Article
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis.
- Published in:
- Life (2075-1729), 2021, v. 11, n. 9, p. 927, doi. 10.3390/life11090927
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Biologic Agents in the Era of Precision Medicine.
- Published in:
- Annals of Laboratory Medicine, 2020, v. 40, n. 2, p. 95, doi. 10.3343/alm.2020.40.2.95
- By:
- Publication type:
- Article
Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1046810
- By:
- Publication type:
- Article
Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.977265
- By:
- Publication type:
- Article
Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.940713
- By:
- Publication type:
- Article
Case Report: "Primary Immunodeficiency"—Severe Autoimmune Enteropathy in a Pediatric Heart Transplant Recipient Treated With Abatacept and Alemtuzumab.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
The Risk of Adverse Effects of TNF-α Inhibitors in Patients With Rheumatoid Arthritis: A Network Meta-Analysis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.814429
- By:
- Publication type:
- Article
Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis.
- Published in:
- Case Reports in Transplantation, 2016, p. 1, doi. 10.1155/2016/7137584
- By:
- Publication type:
- Article
Efficacy of synbiotic supplementation in improving rheumatoid arthritis.
- Published in:
- Research in Pharmaceutical Sciences, 2020, v. 15, n. 3, p. 263, doi. 10.4103/1735-5362.288432
- By:
- Publication type:
- Article
Individualized Drug Repositioning For Rheumatoid Arthritis Using Weighted Kolmogorov–Smirnov Algorithm.
- Published in:
- Pharmacogenomics & Personalized Medicine, 2019, v. 12, p. 369, doi. 10.2147/PGPM.S230751
- By:
- Publication type:
- Article
Biologic Therapies for Giant Cell Arteritis.
- Published in:
- Biologics: Targets & Therapy, 2021, v. 15, p. 17, doi. 10.2147/BTT.S229662
- By:
- Publication type:
- Article
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 41, doi. 10.2147/BTT.S55783
- By:
- Publication type:
- Article
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.
- Published in:
- Biologics: Targets & Therapy, 2014, v. 8, p. 41, doi. 10.2147/BTT.S55783
- By:
- Publication type:
- Article